Practical health co-operation – a cluster randomised study. The impact of referral templates on quality of care and health care co-operation between primary and secondary care
Permanent lenke
https://hdl.handle.net/10037/17094Dato
2019-12-17Type
Doctoral thesisDoktorgradsavhandling
Forfatter
Wåhlberg, HenrikSammendrag
Har del(er)
Paper I: Wåhlberg, H., Valle, P.C., Malm, S. & Broderstad, A.R. (2015). Impact of referral templates on the quality of referrals from primary to secondary care: a cluster randomised trial. BMC Health Services Research, 15, 353. Also available in Munin at https://hdl.handle.net/10037/8830.
Paper II: Wåhlberg, H., Braaten, T. & Broderstad, A.R. (2016). Impact of referral templates on patient experience of the referral and care process: a cluster randomised trial. BMJ Open, 6, e011651. Also available in Munin at https://hdl.handle.net/10037/10667.
Paper III: Wåhlberg, H., Valle, P.C., Malm, S., Hovde, Ø. & Broderstad, A.R. (2017). The effect of referral templates on out-patient quality of care in a hospital setting: a cluster randomized controlled trial. BMC Health Services Research, 17, 177. Also available in Munin at https://hdl.handle.net/10037/12168.
Forlag
UiT The Arctic University of NorwayUiT Norges arktiske universitet
Metadata
Vis full innførselSamlinger
Følgende lisensfil er knyttet til denne innførselen:
Relaterte innførsler
Viser innførsler relatert til tittel, forfatter og emneord.
-
Cochrane Collaboration Systematic Reviews may be based on trials not approved by a research ethics committee
Jokstad, Asbjørn (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-10-27)Systematic reviews (SR) may potentially contain reports of primary trials with ethical problems. The Cochrane Collaboration SRs are considered as the highest standard in evidence-based health care resources. All SRs completed during the last 5 years (2013–2017) under the management of the Oral Health Group of the Cochrane Collaboration were identified. All primary trials included in the Oral Health ... -
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis
Norum, Jan; Antonsen, Margaret Aarag; Tollåli, Geir; Al-Shibli, Khalid; Andersen, Gry; Svanqvist, Kristin-Helene; Helbekkmo, Nina (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-07-29)1 Norum J, et al . ESMO Open 2017; 2 :e000222. doi:10.1136/esmoopen-2017-000222 Open Access Abstr A ct Background P embrolizumab is a new drug approved in several countries for second-line therapy in non-small cell lung cancer (NSCLC) being programmed cell death ligand (PD-L1) positive. This drug has a high cost, and the cost- effectiveness ratio has been debated. Patients ... -
The Use of eHealth and Provider-Based Health Services by Patients with Diabetes Mellitus: Protocol for a Cross-Sectional Study
Hansen, Anne Helen; Bradway, Meghan; Brož, Jan; Claudi, Tor; Henriksen, Øystein; Wangberg, Silje C; Årsand, Eirik (Journal article; Tidsskriftartikkel; Peer reviewed, 2016-10-31)<b>Background:</b> The prevalence of diabetes and the use of electronic health (eHealth) resources are increasing. People with diabetes need frequent monitoring and follow-up of health parameters, and eHealth services can be of great significance in this regard. However, little is known about the extent to which different kinds of eHealth tools are used, and how the use of eHealth is associated ...